Serum neurofilament light chain predicts spinal cord atrophy in neuromyelitis optica spectrum disorder

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study

(2022) Ingrid Anne Lie et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials

(2022) Tjalf Ziemssen et al.   Frontiers in Immunology

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD

(2022) Giulia Fadda et al.   Frontiers in Neurology

Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder

(2021) Hyunjin Kim et al.   Multiple Sclerosis Journal

Spinal Cord Atrophy in Neuromyelitis Optica Spectrum Disorders Is Spatially Related to Cord Lesions and Disability

(2020) Laura Cacciaguerra et al.   RADIOLOGY

Identification and measurement of cervical spinal cord atrophy in neuromyelitis optica spectrum disorders (NMOSD) and correlation with clinical characteristics and cervical spinal cord MRI data

(2020) F. Lersy et al.   REVUE NEUROLOGIQUE

Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases

(2020) Eun‐Jae Lee et al.   Annals of Clinical and Translational Neurology

Reference values for plasma neurofilament light chain (NfL) in healthy Chinese

(2020) Jingshan Chen et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Neuromyelitis optica

(2020) Sven Jarius et al.   Nature Reviews Disease Primers

Brain volumes quantification from MRI in healthy controls: Assessing correlation, agreement and robustness of a convolutional neural network-based software against FreeSurfer, CAT12 and FSL

(2020) Hernán Chaves et al.   JOURNAL OF NEURORADIOLOGY

Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder

(2019) Y. Nakamura et al.   EUROPEAN JOURNAL OF NEUROLOGY

Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD

(2019) Mitsuru Watanabe et al.   NEUROLOGY

MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders

(2018) C. Chien et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

(2018) Christian Barro et al.   BRAIN

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity

(2018) Claudia Chien et al.   Multiple Sclerosis Journal

Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS

(2017) Yaou Liu et al.   EUROPEAN RADIOLOGY

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

(2017) Fredrik Piehl et al.   Multiple Sclerosis Journal

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

(2017) Fredrik Piehl et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

(2015) Dean M. Wingerchuk et al.   NEUROLOGY

Spinal cord gray matter atrophy correlates with multiple sclerosis disability

(2014) Regina Schlaeger et al.   ANNALS OF NEUROLOGY

Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases

(2010) A. Petzold et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY